Skip Navigation

European Heart Journal 1998 19(3):458-465; doi:10.1053/euhj.1997.0802
Copyright © 1998 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (11)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Scholz, K.H.
Right arrow Articles by Kreuzer, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scholz, K.H.
Right arrow Articles by Kreuzer, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Complications of intra-aortic balloon counterpulsation.The role of catheter size and duration of support in a multivariate analysis of risk

K.H. Scholz, S. Ragab, F. von zur Mühlen, T. Schröder, G.S. Werner, L. Mindel and H. Kreuzer

Department of Cardiology, Center for Internal Medicine, University of Göttingen, Göttingen, Germany
Department of Medical Informatics, University of Göttingen, Göttingen, Germany

accepted September 19, 1997

Aims

The aim of this study was to assess the risk of intra-aortic balloon counterpulsation and to identify clinical and procedural variables that would predict complications.

Methods and Results

We analysed 381 consecutive patients who were treated between 1977 and 1995 at our catheterization laboratory and/or medical intensive care unit. The complications considered relevant were limb ischaemia requiring catheter removal, vascular injury, bleeding requiring transfusion, embolic events, and infection. In eight patients the balloon could not be inserted. The rate of complications for the remaining 373 patients was 12·9%. Between 1977 and 1980, surgical insertion was performed using a 12 French catheter with a complication rate of 30·4% (seven of 23 patients). Percutaneous implantation, performed after 1981, had an overall complication rate of 11·7% (41 of 350 patients). Using thinner catheters for percutaneous placement was associated with a reduction in the rate of complications, from 20·7% (17 of 82 patients) for 12 French catheters to 9·9% (10 of 101 patients) for 10·5 French catheters (P=0·04), and 8·4% (14 of 167 patients) for 9·5 French catheters (P=0·006).Multivariate logistic regression analysis identified dur-ation of counterpulsation >48h (odds ratio 3·6), catheter size (odds ratio 3·4 for 12 French catheters), peripheral vascular disease (odds ratio 2·7), and shock (odds ratio 2·0) as independent risk factors for counterpulsation-associated complications. When considering 9·5 French catheters only (167 patients, all after 1992), the sole remaining independent risk factor was duration of counterpulsation >48h (odds ratio 3·8). Those patients with 9·5 French catheters in whom counterpulsation did not exceed 48h had a low complication rate of 3·9%.

Conclusion

The rate of percutaneous intra-aortic balloon counterpulsation complications was thus significantly reduced by employing thinner catheters. It was at an acceptable level for 9·5 French catheters, where a long duration of counterpulsation emerged as the most sig-nificant factor associated with complications. Whether using even thinner catheters in combination with a sheathless implantation technique further minimizes the risk of counterpulsation remains to be seen.

Key Words: Intra-aortic balloon counterpulsation • cardiac assist devices • complications • duration of counterpulsation • thrombolysis

Correspondence: Dr Karl H. Scholz, Department of Cardiology, Center for Internal Medicine, Georg-August University of Göttingen, Robert-Koch Str. 40, 37075 Göttingen, Germany.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Eur Heart JHome page
J. M. Cheng, C. A. den Uil, S. E. Hoeks, M. van der Ent, L. S.D. Jewbali, R. T. van Domburg, and P. W. Serruys
Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials
Eur. Heart J., September 1, 2009; 30(17): 2102 - 2108.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
J. T Christenson, J. Sierra, J.-A. Romand, M. Licker, and A. Kalangos
Long Intraaortic Balloon Treatment Time Leads to More Vascular Complications
Asian Cardiovasc Thorac Ann, October 1, 2007; 15(5): 408 - 412.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
J. Mand'ak, V. Lonsky, J. Dominik, and P. Zacek
Vascular Complications of the Intra-aortic Balloon Counterpulsation
Angiology, January 1, 2005; 56(1): 69 - 74.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. J.F. Baskett, W. A. Ghali, A. Maitland, and G. M. Hirsch
The intraaortic balloon pump in cardiac surgery
Ann. Thorac. Surg., October 1, 2002; 74(4): 1276 - 1287.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.